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Results. Among 775 CA-APN patients, 587 with FQ susceptibility results were analyzed. Numbers of FQ-R and fluoroquinolone-susceptible (FQ-S) group were 127 (21.6%) and 460 (78.4%). In clinical characteristics, more patients in FQ-R group had an age >65 years (56.7% vs 44.6%, p = 0.015), history of antibiotics usage within 1 year (48.1% vs 24.3%, p < 0.001), history of admission within 1 year (43.7% vs 22.8%, p<0.001), Charlson co-morbidity index >1 (26.8% vs 21.3%, p = 0.191), and extendedspectrum β-lactamase positivity (27.2% vs 4.2%, p < 0.001). Clinical response within 72 hours (early clinical response, ECR), final clinical response and mortality were not different between the two groups, although duration of hospitalization was longer in FQ-R group (median 9.0 vs 7.0 days, p = >0.001). In subgroup of 142 subjects using FQ during initial 72 hours, final clinical response or mortality was not different between the two groups. However, ECR was more frequent (50.0% vs 75.0%, p = 0.012) and duration of hospitalization was shorter (median 10.5 vs 7.0 days, p<0.001) in FQ-S than FQ-R group. Multivariate logistic regression proved that age >65 years (OR 1.572, CI 1.004-2.460, p = 0.048) and history of antibiotics usage within 1year (OR 2.902, CI 1.842-4.573, p < 0.001) were significant risk factors for FQ-R. Among the 142 subjects, FQ MICs of Escherichia colifrom urine or blood were available in 64 patients, and ECR according to FQ MIC was analyzed: 72.5% (29/40) in patients with MIC <0.004 ∼ 0.125 µg/ml, 76.9% (10/12) with 0.19 ∼ 3 µg/ml, 80% (4/5) with 4 ∼ 16 µg/ ml and 57.1% (4/7) with >32 µg/ml.
Conclusion. Risk factors of FQ-R were age >65 years and history of antibiotics usage within 1 year, and duration of hospitalization was longer in FQ-R than FQ-S group. Patients with FQ MIC ≤16 µg/ml showed a similar ECR to those with susceptible isolates.
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